Access to Advanced Health Institute (AAHI) has selected Quratis, a biotechnology company and advanced CDMO, as its preferred manufacturer for high-quality pre-clinical and clinical vaccine supplies. This collaboration aims to accelerate the development of AAHI’s vaccine candidates targeting deadly diseases such as tuberculosis, and of vaccines that rely on AAHI’s vaccine adjuvants to provide protection against malaria, HIV, and other global health threats. Quratis brings a GMP-certified biopl...